Authors: DEJONGE J HEIRMAN C DEVEERMAN M VANMEIRVENNE S MOSER M LEO O THIELEMANS K

Citation: J. Dejonge et al., IN-VIVO RETARGETING OF T-CELL EFFECTOR FUNCTION BY RECOMBINANT BISPECIFIC SINGLE-CHAIN FV (ANTI-CD3 X ANTIIDIOTYPE) INDUCES LONG-TERM SURVIVAL IN THE MURINE BCL1 LYMPHOMA MODEL, The Journal of immunology (1950), 161(3), 1998, pp. 1454-1461

Authors: LESPAGNARD L METTENS P VERHEYDEN AM TASIAUX N THIELEMANS K VANMEIRVENNE S GELDHOF A DEBAETSELIER P URBAIN J LEO O MOSER M

Citation: L. Lespagnard et al., DENDRITIC CELLS FUSED WITH MASTOCYTOMA-CELLS ELICIT THERAPEUTIC ANTITUMOR IMMUNITY, International journal of cancer, 76(2), 1998, pp. 250-258

Authors: ZHU D VANARKEL C KING CA VANMEIRVENNE S DEGREEF C THIELEMANS K RADL J STEVENSON FK

Citation: D. Zhu et al., IMMUNOGLOBULIN V-H GENE SEQUENCE-ANALYSIS OF SPONTANEOUS MURINE IMMUNOGLOBULINSECRETING B-CELL TUMORS WITH CLINICAL-FEATURES OF HUMAN-DISEASE, Immunology, 93(2), 1998, pp. 162-170

Authors: DEJONGE J HEIRMAN C DEVEERMAN M VANMEIRVENNE S DEMANET C BRISSINCK J THIELEMENS K

Citation: J. Dejonge et al., BISPECIFIC ANTIBODY TREATMENT OF MURINE B-CELL LYMPHOMA, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 162-165

Authors: VANDERKERKEN K RADL J VANMEIRVENNE S DEVEERMAN M THIELEMANS K VANCAMP B

Citation: K. Vanderkerken et al., HOMING OF MULTIPLE-MYELOMA CELLS TO THE BONE-MARROW - STUDY IN THE 5TMM MOUSE MODELS, Experimental hematology, 25(8), 1997, pp. 421-421

Authors: VANDERKERKEN K DERAEVE H GOES E VANMEIRVENNE S RADL J VANRIET I THIELEMANS K VANCAMP B

Citation: K. Vanderkerken et al., ORGAN INVOLVEMENT AND PHENOTYPIC ADHESION PROFILE OF 5T2 AND 5T33 MYELOMA CELLS IN THE C57BL KALWRIJ MOUSE/, British Journal of Cancer, 76(4), 1997, pp. 451-460